Dynamics of blood counts during the treatment of erythremia (polycythemia) using bioresonance and induction therapy

AUTHORS : Islamov B.I. | Gotovsky Yu.V.

RELEVANT UNIVERSITIES : Institute of Theoretical and Experimental Biophysics RAS, Pushchino); Federal scientificClinical and Experimental Center for Traditional Diagnostics and treatment of the Ministry of Health, Center “IMEDIS “, Moscow, Russia 

YEAR : 2003 | Category : Method of Treatment

By the end of the 20th century, cardiovascular diseases (CVD) remain the main cause of death in most of the developed countries of Europe, accounting for up to 40% of all deaths in this region [1]. At the same time, the countries of the European region differ in terms of mortality rates from CVD. Most of the countries of Central and Eastern Europe have high mortality rates compared to those in the rest of the countries.

In certain age groups, mortality rates between European countries differ by about 7 times. Between 1970 and 1992 CVD mortality rates have also varied across Europe, with declining rates in Southwestern Europe, while increasing rates in Central and Eastern Europe. Over the past 30 years, the share of CVDs in the structure of mortality in the Russian population has practically not changed, accounting for over 50% of all deaths in different periods [2].